Luis "King Kong" Ortiz Tests Positive for Banned Substances

Luis "King Kong" Ortiz Tests Positive for Banned Substances

Published: September 29, 2017


2017 has been a tremendous year for the sport of boxing, but this is not mutually exclusive to all fighters.  WBC Heavyweight champion Deontay “The Bronze Bomber” Wilder (38-0, 37 KOs) for the second time this year will likely have to find a new opponent to defend his title against on November 4th as his opponent Luis “King Kong” Ortiz (27-0, 23 KOs) tested positive for two banned substances. 

The Voluntary Anti-Doping Association (VADA) reported to WBC president Mauricio Sulaiman that Ortiz tested positive for two banned diuretics. The diuretics are chlorothiazide and hydrochlorothiazide, which can be used as a treatment for blood pressure. Unfortunately for Ortiz, these substances can also be masking agents for other performance-enhancing drugs (PED). 

Ortiz may legitimately only have taken the blood pressure treatment, but there won’t be much sympathy for the Cuban since this is not his first time testing positive. Back in 2014 after a bout with Lateef Kayode, Ortiz tested positive for the anabolic steroid nandrolone. The victory over Kayode for Ortiz was changed to a no decision to go along with a fine and suspension from the Las Vegas Athletic Commission. 

For the knockout puncher from Alabama, this is the third time in a row that a scheduled fight had to be changed or canceled due to the other party testing positive for PED's. In 2016, a highly anticipated bout with Russian Alexander Povetkin was canceled due to Povetkin testing positive for the banned substance meldonium. At the beginning of 2017 in February, Wilder was scheduled to face Polish heavyweight Andrzej Wawrzyk. After Wawrzyk failed to pass a test administered by VADA he was replaced by Gerald Washington. Wilder stopped Washington in the fifth round after somewhat of a slow start. 

Deontay Wilder stopped Gerald Washington in the fifth round this past February. Photo: Ryan Hafey/Premier Boxing Champions

Deontay Wilder stopped Gerald Washington in the fifth round this past February. Photo: Ryan Hafey/Premier Boxing Champions

The bout between Wilder and Ortiz was highly anticipated in the boxing world as it pitted two undefeated heavyweight punchers together. It would have been the biggest test of Wilder’s career and an opportunity to show the world that despite any technical deficiencies he may have he is the number one heavyweight. Ortiz has been regarded as the heavyweight nobody wanted to fight. The Wilder bout was the Cuban’s opportunity to cross that threshold to become a legitimate titleholder leading him to bigger fights in the future. 

There may be some appeals to the testing as Ortiz has the right to have a “B” sample tested. Ortiz and his team made a mistake by not disclosing all the medicines and treatments being taken to VADA. This may have led to VADA considering some exception and the fight not being in any jeopardy. 

Wilder will likely have to look for a new opponent if he still wants to fight on November 4th. Wilder’s mandatory that was paid a step aside fee to make the fight with Ortiz happen is former foe Bermane Stiverne. Stiverne was scheduled to fight on the card against Dominic Breazeale. Wilder has not fought since February, and a rematch with Stiverne may be the best option for him at this point. 

More details to follow soon.
 


(Feature Photo: Patrick Smith/Getty Images)

Terrell Gausha ready to threaten Erislandy Lara's 154lb reign in Brooklyn

Terrell Gausha ready to threaten Erislandy Lara's 154lb reign in Brooklyn

Who Should Be Miguel Cotto's Last Opponent?

Who Should Be Miguel Cotto's Last Opponent?